Predict your next investment

HEALTHCARE | Medical Devices & Equipment / Surgical Devices
vclosure.com

See what CB Insights has to offer

About Vascular Closure Systems

a medical device company, based in part on intellectual property of CardioVascular Technologies, Inc. (http://cvtechinc.com), and is focused on the development and commercialization of the vascular access closure technology for the Interventional Cardiology market. The company is comprised of several seasoned medical device professionals and physicians, with a proven record of innovation, clinical acumen, access to the industry and successful commercialization of multiple medical device technologies.

Vascular Closure Systems Headquarter Location

Palo Alto, California, 94301,

United States

Latest Vascular Closure Systems News

Vascular Closure Systems Inc Product Pipeline Analysis 2018 Update Report Updated 13062018 Prices from USD $750

Jul 28, 2018

07:42 EDT 28 Jul 2018 | BioPortfolio Reports Summary Vascular Closure Systems Inc VCS is a medical device company that manufactures and commercializes vascular access closure technology for interventional cardiology market. The company is currently securing funding to complete regulatory and clinical requirements to facilitate commercialization of its advanced vascular access closure technology. It also has completed clinical trial of bioabsorbable vascular access closure system. The company operates in Austria, Belgium, Canada, the Czech Republic, Egypt, Holland, Italy, Japan, South Korea, Luxembourg, Portugal, Saudi Arabia, South Africa, Spain, Slovakia, Switzerland, Turkey and the UAE. VCS is headquartered in Las Vegas, Nevada, the US. This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. Scope: The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments The report analyzes all pipeline products in development for the company Vascular Closure Systems Inc The report provides pipeline analysis on all pipeline products of the company by equipment type, by indication, by development stage, and by trial status The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indications, applications and estimated launch date The report provides detailed description of products in development, technical specification and functions The report also covers ongoing clinical trials wherever applicable with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date. Reasons to Buy: Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio To formulate effective Research Development strategies Develop marketentry and market expansion strategies Exploit inlicensing and outlicensing opportunities by identifying products, most likely to ensure a robust return Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline Identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc Identify, understand and capitalize the next highvalue products that your competitor would add in its portfolio Note: Some sections may be missing if data is unavailable for the company Related Biotechnology, Pharmaceutical and Healthcare News

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.